These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 4151260)

  • 1. Letter: Side effects of chlorpromazine and piperacetazine.
    Ananth J; Kulkarni AS
    Am J Psychiatry; 1974 Jun; 131(6):722. PubMed ID: 4151260
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparative evaluation of injectable chlorpromazine and piperacetazine.
    McLaughlin B; Kulkarni AS
    Psychosomatics; 1973; 14(4):220-1. PubMed ID: 4152813
    [No Abstract]   [Full Text] [Related]  

  • 3. Adverse reactions to chlorpromazine in psychiatric patients.
    Swett C
    Dis Nerv Syst; 1974 Nov; 35(11):509-11. PubMed ID: 17896459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical effectiveness of piperacetazine injection in schizophrenic patients: a controlled study.
    Kulkarni AS
    Adv Biochem Psychopharmacol; 1974; 9(0):691-9. PubMed ID: 4151770
    [No Abstract]   [Full Text] [Related]  

  • 5. Piperacetazine and chlorpromazine: a comparison.
    Johnson AC; Kulkarni AS
    Am J Psychiatry; 1973 May; 130(5):603-5. PubMed ID: 4144711
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical application of the concept of relative potency: an example involving chlorpromazine and haloperidol.
    Preskorn SH
    J Psychiatr Pract; 2005 Jul; 11(4):258-61. PubMed ID: 16041236
    [No Abstract]   [Full Text] [Related]  

  • 7. Allergic and photoallergic conditions from unusual chlorpromazine exposure: report of three cases.
    Giomi B; Difonzo EM; Lotti L; Massi D; Francalanci S
    Int J Dermatol; 2011 Oct; 50(10):1276-8. PubMed ID: 21950296
    [No Abstract]   [Full Text] [Related]  

  • 8. What is appropriate disclosure?
    Cohen D
    Can Fam Physician; 1999 Sep; 45():2036, 2038. PubMed ID: 10509210
    [No Abstract]   [Full Text] [Related]  

  • 9. Chlorpromazine dose for people with schizophrenia.
    de Haan S; Liu X
    Schizophr Bull; 2009 May; 35(3):491-2. PubMed ID: 19342426
    [No Abstract]   [Full Text] [Related]  

  • 10. Evaluation of piperacetazine (Quide) injection in acute schizophrenics.
    Kiev A; Güclü B; Kulkarni AS
    Curr Ther Res Clin Exp; 1972 Jul; 14(7):376-80. PubMed ID: 4625517
    [No Abstract]   [Full Text] [Related]  

  • 11. A comparison of antipsychotic drug-defined daily doses versus chlorpromazine equivalent doses in patients with or without extrapyramidal motor symptoms.
    Barr AM; Honer WG; Johnson JL; Wu TK; Procyshyn RM
    J Clin Psychopharmacol; 2010 Dec; 30(6):741-3. PubMed ID: 21057241
    [No Abstract]   [Full Text] [Related]  

  • 12. Psychopharmacological treatment of schizophrenia.
    Lehmann HE
    Schizophr Bull; 1975; (13):27-45. PubMed ID: 1851
    [No Abstract]   [Full Text] [Related]  

  • 13. Ocular changes associated with long term phenothiazine usage.
    Alexander TA; John JK; Thomas A; Verghese A
    Indian J Ophthalmol; 1985; 33(1):27-31. PubMed ID: 2867036
    [No Abstract]   [Full Text] [Related]  

  • 14. Letter: Piperacetazine-induced failure to ejaculate.
    Jeffries JJ
    Can Psychiatr Assoc J; 1974 Jun; 19(3):322-3. PubMed ID: 4152178
    [No Abstract]   [Full Text] [Related]  

  • 15. A long-term pilot study of pipothiazine palmitate in chronic schizophrenia.
    Villeneuve A; Pires A; Jus A; Lachance R; Drolet A
    Curr Ther Res Clin Exp; 1972 Nov; 14(11):696-706. PubMed ID: 4404626
    [No Abstract]   [Full Text] [Related]  

  • 16. Hypogammaglobulinemia during antipsychotic therapy.
    Abe S; Suzuki T; Hori T; Baba A; Shiraishi H
    Psychiatry Clin Neurosci; 1998 Feb; 52(1):115-7. PubMed ID: 9682944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Letter: Fatal aplastic anemia with piperacetazine therapy.
    Yeung KY; Corn M
    Ann Intern Med; 1974 Sep; 81(3):411. PubMed ID: 4152939
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical experience with pipothiazine palmitate (19552 R.P.) in hospitalized and open ward patients with functional psychoses.
    Salvesen C; Vaksdal K
    Behav Neuropsychiatry; 1973 Oct-1974 Mar; 5(7-12):3-7. PubMed ID: 4154740
    [No Abstract]   [Full Text] [Related]  

  • 19. What is your diagnosis? Hyperpigmentation due to long-term chlorpromazine use.
    Kass J; Hsu S
    Cutis; 2001 Oct; 68(4):252, 260. PubMed ID: 11710442
    [No Abstract]   [Full Text] [Related]  

  • 20. Interpatient variations in antipsychotic therapy.
    McIntyre IM; Gershon S
    J Clin Psychiatry; 1985 May; 46(5 Pt 2):3-5. PubMed ID: 2859279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.